Satisfaction, Adherence and Health-Related Quality of Life with Transdermal Buprenorphine Compared with Oral Opioid Medications in the Usual Care of Osteoarthritis Pain

por Conaghan, Philip G., Serpell, Michael, McSkimming, Paula, Junor, Rod, Dickerson, Sara
Publicado 2016

Multimethod quantitative benefit‐risk assessment of treatments for moderate‐to‐severe osteoarthritis

por Mauer, Jonathan, Bullok, Kristin, Watt, Stephen, Whalen, Ed, Russo, Leo, Junor, Rod, Markman, John, Hauber, Brett, Tervonen, Tommi
Publicado 2022

Subcutaneous tanezumab for osteoarthritis of the hip or knee: efficacy and safety results from a 24-week randomised phase III study with a 24-week follow-up period

por Berenbaum, Francis, Blanco, Francisco J, Guermazi, Ali, Miki, Kenji, Yamabe, Takaharu, Viktrup, Lars, Junor, Rod, Carey, William, Brown, Mark T, West, Christine R, Verburg, Kenneth M
Publicado 2020

Subcutaneous tanezumab for osteoarthritis: Is the early improvement in pain and function meaningful and sustained?

por Berenbaum, Francis, Langford, Richard, Perrot, Serge, Miki, Kenji, Blanco, Francisco J, Yamabe, Takaharu, Isogawa, Naoki, Junor, Rod, Carey, William, Viktrup, Lars, West, Christine R, Brown, Mark T, Verburg, Kenneth M
Publicado 2021